Roger E. Markwell

1.5k total citations
42 papers, 1.1k citations indexed

About

Roger E. Markwell is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Roger E. Markwell has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 16 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Roger E. Markwell's work include Alzheimer's disease research and treatments (7 papers), Peptidase Inhibition and Analysis (6 papers) and Synthetic Organic Chemistry Methods (6 papers). Roger E. Markwell is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Peptidase Inhibition and Analysis (6 papers) and Synthetic Organic Chemistry Methods (6 papers). Roger E. Markwell collaborates with scholars based in United Kingdom, United States and Spain. Roger E. Markwell's co-authors include David Howlett, Ashley R. George, Davina E. OWEN, Robin V. Ward, Harry Wadsworth, K.H. Jennings, Jane E. SWATTON, Stephen Wood, Claus Spitzfaden and Amanda Perry and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Roger E. Markwell

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger E. Markwell United Kingdom	18	439	430	316	244	164	42	1.1k
Craig A. Coburn United States	20	679 1.5×	532 1.2×	233 0.7×	283 1.2×	247 1.5×	34	1.4k
Michael A. Brodney United States	20	758 1.7×	272 0.6×	136 0.4×	185 0.8×	116 0.7×	38	1.1k
Adrian Hall United Kingdom	24	1.0k 2.3×	414 1.0×	158 0.5×	257 1.1×	83 0.5×	62	1.5k
Yū Momose Japan	16	502 1.1×	1.0k 2.4×	169 0.5×	136 0.6×	73 0.4×	30	1.7k
Y. Kawamatsu Japan	18	476 1.1×	706 1.6×	160 0.5×	192 0.8×	39 0.2×	44	1.2k
Daniela Pizzirani Italy	22	645 1.5×	717 1.7×	207 0.7×	340 1.4×	165 1.0×	32	1.6k
Janet Sredy United States	18	548 1.2×	623 1.4×	174 0.6×	111 0.5×	36 0.2×	30	1.4k
David A. Claremon United States	24	992 2.3×	538 1.3×	76 0.2×	183 0.8×	43 0.3×	50	1.7k
Daniel Oehlrich Belgium	21	711 1.6×	450 1.0×	219 0.7×	162 0.7×	226 1.4×	36	1.3k
Rita Maria Concetta Di Martino Italy	18	281 0.6×	373 0.9×	151 0.5×	201 0.8×	124 0.8×	32	1.0k

Countries citing papers authored by Roger E. Markwell

Since Specialization

Citations

This map shows the geographic impact of Roger E. Markwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger E. Markwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger E. Markwell more than expected).

Fields of papers citing papers by Roger E. Markwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger E. Markwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger E. Markwell. The network helps show where Roger E. Markwell may publish in the future.

Co-authorship network of co-authors of Roger E. Markwell

This figure shows the co-authorship network connecting the top 25 collaborators of Roger E. Markwell. A scholar is included among the top collaborators of Roger E. Markwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger E. Markwell. Roger E. Markwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Miles, Timothy J., Alan J. Hennessy, B.D. Bax, et al.. (2016). Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 26(10). 2464–2469. 33 indexed citations

2.

Miles, Timothy J., Gerald Brooks, Pamela Brown, et al.. (2011). Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 21(24). 7483–7488. 33 indexed citations

3.

Assinder, Stephen J., Gary Christie, Grant Mason, et al.. (2000). Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells. Biochemical Journal. 346(2). 447–454. 43 indexed citations

4.

Assinder, Stephen J., Gary Christie, Grant Mason, et al.. (2000). Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells. Biochemical Journal. 346(2). 447–447. 7 indexed citations

5.

Howlett, David, Ashley R. George, Davina E. OWEN, Robin V. Ward, & Roger E. Markwell. (1999). Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation.. PubMed. 343 Pt 2. 419–23. 114 indexed citations

6.

Tarling, Chris A., Andrew B. Holmes, Roger E. Markwell, & Neil D. Pearson. (1999). β-, γ- and δ-Lactams as conformational constraints in ring-closing metathesis. Journal of the Chemical Society Perkin Transactions 1. 1695–1702. 41 indexed citations

7.

Howlett, David, Amanda Perry, Jane E. SWATTON, et al.. (1999). Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans. Biochemical Journal. 340(1). 283–289. 100 indexed citations

8.

Allsop, David, G.S. Christie, Sandra L. Holmes, et al.. (1997). Studies on inhibition of β-amyloid formation in APP-751-transfected IMR-32 cells, and SPA4CT-transfected SHSY5Y cells. Lancaster EPrints (Lancaster University). 2 indexed citations

9.

Boyfield, Izzy, Martyn C. Coldwell, Michael S. Hadley, et al.. (1996). Novel 2,5-disubstituted-1H-pyrroles with high affinity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 6(11). 1233–1236. 10 indexed citations

10.

Allsop, David, G.S. Christie, Sandra L. Holmes, et al.. (1996). 588 Studies on inhibition of βA4 formation in APP-751 transfected IMR-32 cells, and SPA4CT transfected SHSYSY cells. Neurobiology of Aging. 17(4). S146–S146.

11.

Karran, Eric, et al.. (1995). A simplein vivo model of collagen degradation using collagen-gelled cotton buds: The effects of collagenase inhibitors and other agents. Inflammation Research. 44(1). 36–46. 4 indexed citations

12.

Karran, Eric, Tim Young, Roger E. Markwell, & Gregory P. Harper. (1995). In vivo model of cartilage degradation–effects of a matrix metalloproteinase inhibitor.. Annals of the Rheumatic Diseases. 54(8). 662–669. 20 indexed citations

13.

Bird, John, Gregory P. Harper, Ian Hughes, et al.. (1995). Inhibitors of human collagenase: dipeptide mimetics with lactam and azalactam moieties at the position. Bioorganic & Medicinal Chemistry Letters. 5(22). 2593–2598. 5 indexed citations

14.

Bird, John, Gregory P. Harper, David J. Hunter, et al.. (1994). Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase. Journal of Medicinal Chemistry. 37(1). 158–169. 123 indexed citations

15.

Bird, John, Laramie M. Gaster, Gregory P. Harper, et al.. (1993). Synthesis of novel modified dipeptide inhibitors of human collagenase: .beta.-mercapto carboxylic acid derivatives. Journal of Medicinal Chemistry. 36(25). 4030–4039. 32 indexed citations

16.

Buckle, Derek R., Keith Foster, John F. Taylor, et al.. (1987). Novel 1H-benzimidazol-4-ols with potent 5-lipoxygenase inhibitory activity. Journal of Medicinal Chemistry. 30(12). 2216–2221. 16 indexed citations

17.

Markwell, Roger E., et al.. (1979). Reactions of diterpenoids in concentrated sulphuric acid. Part 1. Novel rearrangements of tetrahydroabietic acids. Journal of the Chemical Society Perkin Transactions 1. 2930–2930.

18.

Jordan, Steven R., et al.. (1978). The synthesis and oxidation of N-hydroxy-derivatives of the β-adrenoceptor antagonists bufuralol and toliprolol. Journal of the Chemical Society Perkin Transactions 1. 928–933. 6 indexed citations

19.

Cross, B. E. & Roger E. Markwell. (1972). Rearrangements of the gibbane skeleton during dehydrogenations with 2,3-dichloro-5,6-dicyanobenzoquinone. Journal of the Chemical Society Chemical Communications. 442–442. 1 indexed citations

20.

Cross, B. E. & Roger E. Markwell. (1971). New metabolites of Gibberella fujikuroi. Part XVIII. 4bβ,7-Dihydroxy-1-methyl-8-methylenegibba-1,3,4a(10a)-trien-10-one. Journal of the Chemical Society C Organic. 0(0). 2980–2983. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact